Cardarine
Cardarine (GW-501516)
100 tabs × 20 mg/tab
Coming soon
View details Cardarine (GW-501516) →Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.
Selective Androgen Receptor Modulators
Cardarine
Independent batch results for Cardarine (GW-501516) are not yet published. They will be added here once testing is complete.
Product information
20 mg per tablet · 100 tablets · Zyvex Pharmaceuticals
Cardarine (GW-501516) from Zyvex Pharmaceuticals contains cardarine (GW-501516) at 20 mg per tablet and comes in a pack of 100 tablets.
This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.
Cardarine (GW-501516) is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is cardarine (GW-501516), classified as a ppar-delta receptor agonist.
| Property | Details |
|---|---|
| Product name | Cardarine (GW-501516) |
| Manufacturer | Zyvex Pharmaceuticals |
| Active ingredient | Cardarine |
| Strength | 20 mg per tablet |
| Package | 100 tablets |
| Drug class | PPAR-delta receptor agonist |
| Chemical formula | C21H18F3NO3S2 |
| Dosage form and route | Tablet; oral |
A solid tablet for oral administration. Each tablet provides a measured amount of active ingredient. Confirm suitability with a pharmacist before splitting or crushing; appearance and score lines alone do not establish accurate dose division.
Cardarine (GW-501516) from Zyvex Pharmaceuticals contains cardarine. Cardarine, or GW-501516, was investigated as a metabolic drug affecting lipid handling. It acts through PPAR-delta rather than the androgen receptor and should not be described as a SARM.
People seek cardarine for endurance, fat loss and body-composition goals. Short-term metabolic findings do not demonstrate a safe athletic or general wellbeing benefit.
A trial in 268 patients with low HDL cholesterol studied 2.5, 5 or 10 mg daily for 12 weeks. These are historical research exposures, not an established performance protocol. Serious preclinical toxicity concerns remain relevant, and a 20 mg tablet is not a validated exercise dose.
A safe routine human regimen has not been established for cardarine. Serious preclinical toxicity led to abandonment of its development. A 20 mg tablet must not be treated as an evidence-based performance or weight-loss dose.
A complete clinical contraindication profile has not been established. Avoid exposure with known hypersensitivity, during pregnancy or breastfeeding, and in children outside a properly reviewed clinical setting. Absence of a listed contraindication is not evidence of safety.
Serious toxicities, including cancers in long-term animal studies, are a central safety concern. The size and duration of earlier human studies cannot exclude long-latency harm. Claims of improved endurance do not establish safety.
Human interaction studies are limited. A clinician or study team should review all prescription medicines, nonprescription products and supplements. There is no basis for assuming that combinations with other experimental compounds are safe.
Adequate pregnancy, lactation and reproductive safety evidence is lacking. Avoid exposure during pregnancy or breastfeeding. Any reproductive-risk precautions in a clinical study should be directed by the study team.
A complete human adverse-reaction profile and reliable event frequencies are not established. Serious animal toxicology findings remain relevant even when an individual notices no immediate symptoms.
For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.
Cardarine activates PPAR-delta, a nuclear receptor involved in metabolic gene regulation. It is not a selective androgen receptor modulator, despite often being grouped with SARMs in commercial descriptions.
Human exposure data are limited and do not support a validated routine dosing interval for this tablet. A duration of urinary detection or a laboratory clearance estimate cannot establish the duration of safety risk.
Keep tablets sealed in the original container, protected from excessive heat, moisture and accidental access. Use storage and expiry conditions supported by the finished preparation's stability information. A laboratory compound's storage temperature does not establish appropriate medicinal tablet storage. Arrange disposal through a pharmacy or supervising research service.
Browse more
Cardarine
100 tabs × 20 mg/tab
Coming soon
View details Cardarine (GW-501516) →